In the compound-target network, some key compounds are highly central and are used in cardiovascular research: the levels of IL-1β, TNF-α, IL-10, IkBα, and NF-kB in patients with HF are reduced under the treatment of quercetin, showing that quercetin possesses the obvious anti-inflammatory properties [26]. The gene discussed is TNF; the disease is hydrops fetalis.